Javascript must be enabled to continue!
Study on the Epidemiological Characteristics of SARS-CoV-2 Infection Based on Population of Zunyi, China
View through CrossRef
Abstract
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new type of virus that firstly confirmed in Wuhan, China recently. SARS-CoV-2 mainly spread through droplets. Infection characteristics data of SARS-CoV-2 is still limited, especially about asymptomatic infection, familial aggregation infection and infection risk in family member.MethodsFrom 2nd January 2020 to 23th February 2020, we have screened 22,729 throat swab samples from individuals with either have contact history of imported personnel, out-of-city travel or residence history or flu-like symptoms during the past 14 days. SARS-CoV-2 RNA was extracted and detected by real-time PCR. Data were analyzed using SPSS version 19 (IBM, Armonk, NY, USA). The results were confirmed by the Pearson χ2 test; P < 0.05 was considered statistically significant.Results35 SARS-CoV-2 positive patients were found, 22 were asymptomatic infection, and 31 were familial aggregation infection. Odds ratio of SARS-CoV-2 infection risk between family aggregated close contacts and overall close contacts was 29.40 (95% confidence interval: 13.99 - 62.205, χ2 = 140.23, P < 0.001); odds ratio of SARS-CoV-2 infection risk between family aggregated close contacts and non-family aggregated close contacts was 703.50 (95% confidence interval: 89.53 - 5527.95, χ2 = 282.659, P < 0.001). One SARS-CoV-2 positive patient infected 2.08 (25/12) people on average under social control without separate isolation.ConclusionsSocial control is effective in SARS-CoV-2 inhibition, but self-isolation and screening should be added as supplementary means to avoid familial aggregation infection and find out asymptomatic patients.
Research Square Platform LLC
Title: Study on the Epidemiological Characteristics of SARS-CoV-2 Infection Based on Population of Zunyi, China
Description:
Abstract
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new type of virus that firstly confirmed in Wuhan, China recently.
SARS-CoV-2 mainly spread through droplets.
Infection characteristics data of SARS-CoV-2 is still limited, especially about asymptomatic infection, familial aggregation infection and infection risk in family member.
MethodsFrom 2nd January 2020 to 23th February 2020, we have screened 22,729 throat swab samples from individuals with either have contact history of imported personnel, out-of-city travel or residence history or flu-like symptoms during the past 14 days.
SARS-CoV-2 RNA was extracted and detected by real-time PCR.
Data were analyzed using SPSS version 19 (IBM, Armonk, NY, USA).
The results were confirmed by the Pearson χ2 test; P < 0.
05 was considered statistically significant.
Results35 SARS-CoV-2 positive patients were found, 22 were asymptomatic infection, and 31 were familial aggregation infection.
Odds ratio of SARS-CoV-2 infection risk between family aggregated close contacts and overall close contacts was 29.
40 (95% confidence interval: 13.
99 - 62.
205, χ2 = 140.
23, P < 0.
001); odds ratio of SARS-CoV-2 infection risk between family aggregated close contacts and non-family aggregated close contacts was 703.
50 (95% confidence interval: 89.
53 - 5527.
95, χ2 = 282.
659, P < 0.
001).
One SARS-CoV-2 positive patient infected 2.
08 (25/12) people on average under social control without separate isolation.
ConclusionsSocial control is effective in SARS-CoV-2 inhibition, but self-isolation and screening should be added as supplementary means to avoid familial aggregation infection and find out asymptomatic patients.
Related Results
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously evolving, bringing great challenges to the control of the virus. In the...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies
AbstractThe COVID-19 pandemic caused by SARS-CoV-2 has posed a global threat to human lives and economics. One of the best ways to determine protection against the infection is to ...
The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
AbstractThe papain‐like protease (PLpro) is an important enzyme for coronavirus polyprotein processing, as well as for virus‐host immune suppression. Previous studies reveal that a...
Resistance of endothelial cells to SARS-CoV-2 infectionin vitro
Resistance of endothelial cells to SARS-CoV-2 infectionin vitro
AbstractRationaleThe secondary thrombotic/vascular clinical syndrome of COVID-19 suggests that SARS-CoV-2 infects not only respiratory epithelium but also the endothelium activatin...
ASGR1 is a candidate receptor for SARS-CoV-2 that promotes infection of liver cells
ASGR1 is a candidate receptor for SARS-CoV-2 that promotes infection of liver cells
AbstractBackgroud & AimsCurrently, the COVID-19 pandemic, caused by SARS-CoV-2 infection, represents a serious public health problem worldwide. Although it has been shown that ...

